Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

4.840 -0.140 (-2.81%)
Delayed Quote Updated: 1:33 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript ↗
Data licensing revenue surged past full-year fiscal 2026 totals in single quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology Q1 Earnings Call Highlights ↗
Champions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology... 
Via MarketBeat
Topics Earnings
Champions Oncology (NASDAQ:CSBR) Shares Jump as Q1 Margins Expand and Adjusted EBITDA Turns Higher ↗
Via Chartmill
News headline image
Champions Oncology Q4 Earnings Call Highlights ↗
Champions Oncology (NASDAQ:CSBR) reported record revenue for fiscal 2026 and positive adjusted EBITDA in every quarter of the year, supported by growth in its core Translational Oncology Solutions, or... 
Via MarketBeat
Topics Earnings
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock ↗
Via Chartmill
Topics Earnings
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
Via Chartmill
News headline image
Insights Ahead: Champions Oncology's Quarterly Earnings ↗
 
Via Benzinga
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Champions Oncology (CSBR) Earnings Transcript 
Via The Motley Fool
News headline image
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
This SaaS provider enables brands to personalize customer engagement across digital channels using data-driven orchestration tools. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
This marketing technology provider delivers data-driven automation and consumer insights to enterprise clients across multiple channels. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For July 23, 2025 ↗
 
Via Benzinga
News headline image
Recap: Champions Oncology Q2 Earnings ↗
 
Via Benzinga
News headline image
A Peek at Champions Oncology's Future Earnings ↗
 
Via Benzinga
News headline image
A Preview Of Champions Oncology's Earnings ↗
 
Via Benzinga
News headline image
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
Kodiak AI, Inc. delivers AI-powered navigation software for trucking, defense, and industrial fleets using proprietary sensor technology. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
Sprinklr delivers a unified platform for enterprise customer experience management, serving global brands with integrated digital solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Champions Oncology (CSBR) Earnings Call Transcript ↗
Champions Oncology (CSBR) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Champions Oncology (CSBR) Earnings Transcript 
Via The Motley Fool
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins. 
Via Chartmill
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
Via Chartmill
News headline image
Earnings Scheduled For September 15, 2025 ↗
 
Via Benzinga
News headline image
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline. 
Via Benzinga
News headline image
Earnings Scheduled For March 11, 2025 ↗
 
Via Benzinga
News headline image
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For December 11, 2024 ↗
 
Via Benzinga
News headline image
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday ↗
 
Via Benzinga
News headline image
CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 ↗
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.